Recently, we reported that combination of DNA-methyltransferase inhibitor decitabine (DAC) and histone deacetylase inhibitor SAHA triggered p53-dependent apoptosis in leukemia-derived cell line CML-T1. This evidence concerns the gene TP53 and chronic myelogenous leukemia, BCR-ABL1 positive.